Bausch Health Companies Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bausch Health Companies Inc. on December 23, 2025. The report details the final results and expiration of exchange offers for the Company's outstanding senior secured notes.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or margins. The primary financial data relates to a debt restructuring transaction:
- Old Debt: 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028.
- New Debt: Up to $1.6 billion aggregate principal amount of new 10.00% Senior Secured Notes due 2032.
- Issuer: 1261229 B.C. Ltd., an indirect wholly-owned subsidiary of the Company.
Material Changes
The material change reported is the successful conclusion of the exchange offers, which expired at 5:00 p.m. New York City time on December 23, 2025. This transaction extends the maturity of a portion of the Company's debt from 2028 to 2032 and adjusts the interest rate to 10.00% for the new notes.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors beyond the context of the debt exchange. The transaction was executed pursuant to a confidential exchange offer memorandum dated November 24, 2025.
Investor Verification Checklist
- Verify the exact aggregate principal amount of old notes tendered versus the $1.6 billion cap for new notes issued.
- Review the attached press release (Exhibit 99.1) for specific acceptance rates and any remaining outstanding balances of the 2028 notes.
- Confirm the impact of the new 10.00% interest rate on future interest expense compared to the blended rate of the retired notes.
- Check for any covenants or conditions attached to the new 2032 notes that may affect future liquidity.